24
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9567 | Samatasvir | ATOLIHZIXHZSBA-BTSKBWHGSA-N,IDX719 | HCV Protease |
Samatasvir (ATOLIHZIXHZSBA-BTSKBWHGSA-N) is a pan-genotypic inhibitor of the HCV non-structural protein 5A. | |||
T3334 | Velpatasvir | GS-5816 | HCV Protease , SARS-CoV |
Velpatasvir (GS-5816), also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor. GS-5816 has demonstrated pan-genotypic activity and a high barrier to resistance in HCV replicon assays. GS-5816 d... | |||
T1786 | Daclatasvir dihydrochloride | BMS-790052 dihydrochloride | HCV Protease |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to ... | |||
T6229 | Daclatasvir | Daklinza,EBP 883,BMS-790052 | HCV Protease |
Daclatasvir (EBP 883) (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Phase 3. | |||
T25268L | Coblopasvir dihydrochloride | Coblopasvir dihydrochloride(1312608-46-0 Free base) | HCV Protease |
Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor. | |||
T4544 | Elbasvir | MK-8742 | HCV Protease |
Elbasvir (MK-8742) is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection. | |||
T25268 | Coblopasvir | Others | |
Coblopasvir is a pan-genotypic non-structural protein 5A (NS5A) inhibitor. It can be used to study chronic hepatitis C virus infection. | |||
T9957 | LASV inhibitor 3.3 | Virus Protease | |
LASV inhibitor 3.3 is an inhibitor of Lassa fever virus (LASV) targeting lysosome-associated membrane protein 1 (LAMP1), a host factor that binds to the LASV glycoprotein (GP) during infection. | |||
T68015 | Ruzasvir | MK8408,MK-8408,MK 8408 | HCV Protease |
Ruzasvir (MK-8408) is a novel and potent pan-genotypic inhibitor of hepatitis C virus NS5A with antiviral activity. | |||
T7158 | Ombitasvir | ABT-267 | HCV Protease |
Ombitasvir (ABT-267) is an orally bioavailable and potent inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A).with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5, and 366 pM against genotype ... | |||
T6200 | Ledipasvir | GS-5885 | HCV Protease , SARS-CoV |
Ledipasvir (GS-5885) is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor. | |||
T4203 | Ledipasvir (acetone) | Ledipasvir acetone,GS-5885 acetone | HCV Protease |
Ledipasvir (acetone) (GS-5885 acetone) is an HCV NS5A polymerase inhibitor, used for the treatment of hepatitis C virus infection. | |||
T75241 | Ledipasvir hydrochloride | GS-5885 hydrochloride | |
Ledipasvir hydrochloride (GS-5885) is a hepatitis C virus NS5A inhibitor, displaying potent activity with EC50 values of 34 pM for genotype 1a replicon and 4 pM for genotype 1b replicon. Additionally, it acts as a SARS-C... | |||
T74006 | Daclatasvir Impurity B | ||
Daclatasvir Impurity B, a noted impurity of the antiviral agent Daclatasvir, acts as a potent inhibitor of the HCV NS5A protein [1]. | |||
T74007 | Daclatasvir Impurity C | ||
Daclatasvir Impurity C is an impurity found in Daclatasvir, a robust inhibitor of the HCV NS5A protein [1]. | |||
T70731 | Odalasvir | ||
Odalasvir is a novel NS5A inhibitor for the treatment of hepatitis C. | |||
T37915 | Monodes(N-carboxymethyl)valine Daclatasvir | ||
Monodes(N-carboxymethyl)valine Daclatasvir, also known as Daclatasvir Impurity A, is the principal degradation product of Daclatasvir.Daclatasvir is a potent inhibitor of the HCV NS5A protein[1]. | |||
T71964 | Ravidasvir HCl | ||
Ravidasvir, also known as PPI-668 and ASC16, is a second-generation, orally active, potent and selective HCV NS5A protein inhibitor. | |||
T74588 | Yimitasvir diphosphate | ||
Yimitasvir (Emitasvir) diphosphate is an orally administered inhibitor of the hepatitis C virus (HCV) nonstructural protein 5A (NS5A), utilized in the research of chronic hepatitis C virus infection [1]. | |||
T11832 | Ledipasvir D-tartrate | GS-5885 D-tartrate | Others |
Ledipasvir D-tartrate with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon. is an inhibitor of the hepatitis C virus NS5A. | |||
T78669 | (1R,4S)-Yimitasvir diphosphate | (1R,4S)-DAG-181 diphosphate,(1R,4S)-Emitasvir diphosphate | |
Yimitasvir diphosphate, also known as Emitasvir, is an orally-administered inhibitor of the hepatitis C virus (HCV) nonstructural protein 5A (NS5A). It is utilized in the study of chronic hepatitis C virus infections [1]... | |||
T74589 | Yimitasvir | ||
Yimitasvir (Emitasvir), an orally administered inhibitor targeting the hepatitis C virus's (HCV) nonstructural protein 5A (NS5A), shows potential for the exploration of chronic HCV infection treatments [1]. | |||
T64124 | Sunvozertinib | DZD9008,DZD 9008,DZD-9008 | EGFR , BTK |
Sunvozertinib (DZD9008) is a potent ErbBs and BTK inhibitor and has inhibitory effects on EGFR, Her2 and mutant epidermal growth factor. Sunvozertinib showed inhibition of EGFR exon 20 NPH insertion, EGFR exon 20 ASV ins... | |||
T9304 | (S)-Sunvozertinib | N-[5-[[4-[5-Chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,DZD9008 | EGFR , HER |
(S)-Sunvozertinib (DZD9008) is a rationally designed selective, irreversible EGFR/HER2 inhibitor. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04384 | Src Protein, Human, Recombinant (His & GST) | Human | Baculovirus Insect Cells |
Src Protein, Human, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 87.7 kDa and the accession number is P12931-1. |